TAR
0.024
140%
1TT
0.001
-50%
CNJ
0.076
52%
BIT
0.002
-33.3%
NAE
0.003
50%
M2R
0.002
-33.3%
ECS
0.007
40%
KLV
0.005
-28.6%
GG1
0.21
31.3%
APCR
0.003
-25%
EOS
6.46
28.9%
OVT
0.003
-25%
CTO
0.014
27.3%
EXT
0.008
-20%
AAU
0.01
25%
MRQ
0.004
-20%
FTI
0.25
25%
PER
0.008
-20%
MML
0.032
23.1%
RDN
0.004
-20%
ENX
0.28
21.7%
VEN
0.004
-20%
EWC
0.056
21.7%
W2V
0.008
-20%
TEM
0.006
20%
AGR
0.018
-18.2%
AGD
0.13
18.2%
NES
0.005
-16.7%
AX8
0.007
16.7%
ARC
0.096
-16.5%
BNL
0.007
16.7%
TSK
0.115
-14.8%
ENV
0.007
16.7%
CRD
0.6
-14.3%
LCL
0.007
16.7%
HHR
0.006
-14.3%
SER
0.007
16.7%
PIM
0.06
-14.3%
BEZ
0.05
16.3%
AUV
0.013
-13.3%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AVITA Medical (ASX:AVH) signed an exclusive 5 year distribution agreement with Stedical Scientific

AVITA Medical (ASX:AVH) signed an exclusive five year distribution agreement with Stedical Scientific, to commercialise PermeaDerm® Biosynthetic Wound Matrix in the U.S. The matrix is cleared by the U.S. FDA and used for a variety of injuries | https://announcements.asx.com.au/asxpdf/20240111/pdf/05zbp446ftpyw0.pdf #FDA #PermeaDerm #AVH